TrialClinical drug investigation2024

A Single-Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder.

Celine M Laffont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.